Nuveen Asset Management, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$9,588,216
+94804.6%
94,039
-15.4%
0.00%
-25.0%
Q1 2023$10,103
+148.3%
111,121
+3.7%
0.00%
+100.0%
Q4 2022$4,069
-99.9%
107,115
-3.0%
0.00%
+100.0%
Q3 2022$2,775,000
-19.7%
110,433
-2.8%
0.00%0.0%
Q2 2022$3,454,000
-13.4%
113,646
+7.7%
0.00%0.0%
Q1 2022$3,987,000
+55.2%
105,532
+8.3%
0.00%0.0%
Q4 2021$2,569,000
-75.6%
97,415
-7.1%
0.00%
-66.7%
Q3 2021$10,548,000
-55.2%
104,836
-37.0%
0.00%
-57.1%
Q2 2021$23,561,000
+83.9%
166,467
+29.5%
0.01%
+75.0%
Q1 2021$12,813,000
-18.1%
128,506
+1.6%
0.00%
-20.0%
Q4 2020$15,639,000
+58.6%
126,505
+25.0%
0.01%
+25.0%
Q3 2020$9,861,000
-43.0%
101,220
-8.8%
0.00%
-42.9%
Q2 2020$17,315,000
-36.5%
110,980
-41.2%
0.01%
-46.2%
Q1 2020$27,262,000
-18.6%
188,875
+15.2%
0.01%0.0%
Q4 2019$33,511,000
+139.6%
163,926
-5.9%
0.01%
+116.7%
Q3 2019$13,984,000
+9.5%
174,165
+28.7%
0.01%
+20.0%
Q2 2019$12,767,000
+2998.8%
135,312
+2708.5%
0.01%
+150.0%
Q1 2019$412,0004,8180.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$295,368,02659.26%
Ally Bridge Group (NY) LLC 105,558$10,762,69413.04%
First Light Asset Management, LLC 1,432,208$146,027,92811.44%
Boxer Capital, LLC 1,430,004$145,8036.76%
MPM BioImpact LLC 234,478$23,907,3774.81%
Tri Locum Partners LP 96,274$9,816,0973.65%
Altium Capital Management LP 41,485$4,229,8113.20%
Ghost Tree Capital, LLC 85,000$8,666,6002.86%
KRS Capital Management, LLC 27,941$2,848,8642.85%
Sofinnova Investments, Inc. 322,471$32,879,1432.15%
View complete list of REATA PHARMACEUTICALS INC shareholders